


Addressing depression in chronic care settings is vital for improving patient outcomes. Culturally relevant screening programs may optimize the identification of at-risk individuals and facilitate access to appropriate mental health services.

Patients co-infected with HIV and hypertension in South Africa face significant out-of-pocket expenditures, jeopardizing treatment adherence. Integrating non-communicable disease (NCD) care into existing HIV programs is an economic imperative to alleviate p...

Multidisciplinary limb programs offer a cost-effective strategy for managing peripheral arterial disease, particularly in preventing major amputations. Hospitals should evaluate the long-term ROI of such programs, considering reduced readmissions and improv...

Early detection of valvular heart disease can significantly reduce morbidity and mortality, but current screening methods are often costly and inefficient. An AI-enhanced ECG could offer a more accessible and scalable approach, potentially shifting resource...

Smoking-related cataracts are a significant driver of global vision impairment, demanding urgent policy interventions. Without stronger tobacco control, the number of individuals affected will continue to rise, placing further strain on healthcare systems.

The decline in urine microscopy impacts diagnostic accuracy and potentially increases healthcare costs due to reliance on automated, less informative tests. Addressing systemic barriers, such as inadequate reimbursement and training, is essential for preser...

The rising costs of orphan drugs for rare conditions like hereditary angioedema force payers to scrutinize safety data more intensely. Real-world evidence, despite its limitations, may increasingly dictate formulary placement for berotralstat and lanadelumab.

Siloed, referral-based palliative care leaves high-risk opioid patients with cancer vulnerable. Systemic change requires addressing reimbursement models and staffing mandates that perpetuate the status quo.

Patients with inborn errors of immunity (IEI) face delayed diagnoses and inconsistent access to therapies, highlighting critical gaps in healthcare systems. A 30-year analysis of over 30,000 IEI patients underscores the need for policy changes to support ea...

Patients with musculoskeletal disorders and comorbidities face a significant burden due to fragmented care models. Addressing these systemic issues could lead to better outcomes and reduced healthcare expenditures.